LakeShore Biopharma Co (LakeShore Biopharma Co) Inventories, Raw Materials & Components : $0.00 Mil (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Inventories, Raw Materials & Components?

LakeShore Biopharma Co's inventories, raw materials & components for the quarter that ended in Sep. 2023 was $0.00 Mil.

LakeShore Biopharma Co's quarterly raw materials declined from Sep. 2022 ($7.46 Mil) to Mar. 2023 ($7.32 Mil) and declined from Mar. 2023 ($7.32 Mil) to Sep. 2023 ($0.00 Mil).

LakeShore Biopharma Co's annual raw materials increased from Mar. 2021 ($3.21 Mil) to Mar. 2022 ($9.13 Mil) but then declined from Mar. 2022 ($9.13 Mil) to Mar. 2023 ($7.32 Mil).

LakeShore Biopharma Co Inventories, Raw Materials & Components Historical Data

The historical data trend for LakeShore Biopharma Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Inventories, Raw Materials & Components Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Inventories, Raw Materials & Components

3.21

9.13

7.32

LakeShore Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Inventories, Raw Materials & Components	Get a 7-Day Free Trial			-	9.13	7.46	7.32	-

LakeShore Biopharma Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Inventories, Raw Materials & Components

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.